APPLIED UV INC (AUVI)

US0379883004 - Common Stock

0.575  +0.01 (+1.55%)

After market: 0.585 +0.01 (+1.74%)

Fundamental Rating

1

Overall AUVI gets a fundamental rating of 1 out of 10. We evaluated AUVI against 43 industry peers in the Building Products industry. AUVI has a bad profitability rating. Also its financial health evaluation is rather negative. AUVI does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

AUVI had negative earnings in the past year.
AUVI had a negative operating cash flow in the past year.
In the past 5 years AUVI reported 4 times negative net income.
In the past 5 years AUVI reported 4 times negative operating cash flow.

1.2 Ratios

AUVI's Return On Assets of -25.38% is on the low side compared to the rest of the industry. AUVI is outperformed by 95.35% of its industry peers.
The Return On Equity of AUVI (-59.56%) is worse than 90.70% of its industry peers.
Industry RankSector Rank
ROA -25.38%
ROE -59.56%
ROIC N/A
ROA(3y)-33.73%
ROA(5y)-14.6%
ROE(3y)-62.87%
ROE(5y)0.06%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AUVI has a Gross Margin of 19.22%. This is amonst the worse of the industry: AUVI underperforms 81.40% of its industry peers.
In the last couple of years the Gross Margin of AUVI has declined.
The Profit Margin and Operating Margin are not available for AUVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.93%
GM growth 5Y-11.46%

2

2. Health

2.1 Basic Checks

AUVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AUVI has been reduced compared to 1 year ago.
AUVI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AUVI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.26, we must say that AUVI is in the distress zone and has some risk of bankruptcy.
AUVI has a Altman-Z score of -1.26. This is amonst the worse of the industry: AUVI underperforms 95.35% of its industry peers.
AUVI has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
AUVI has a Debt to Equity ratio of 0.18. This is in the better half of the industry: AUVI outperforms 67.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.26
ROIC/WACCN/A
WACC16.4%

2.3 Liquidity

AUVI has a Current Ratio of 0.61. This is a bad value and indicates that AUVI is not financially healthy enough and could expect problems in meeting its short term obligations.
AUVI's Current ratio of 0.61 is on the low side compared to the rest of the industry. AUVI is outperformed by 90.70% of its industry peers.
A Quick Ratio of 0.35 indicates that AUVI may have some problems paying its short term obligations.
AUVI has a worse Quick ratio (0.35) than 90.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.35

3

3. Growth

3.1 Past

AUVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -107.64%.
AUVI shows a strong growth in Revenue. In the last year, the Revenue has grown by 102.03%.
Measured over the past years, AUVI shows a very strong growth in Revenue. The Revenue has been growing by 40.04% on average per year.
EPS 1Y (TTM)-107.64%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-17.8%
Revenue 1Y (TTM)102.03%
Revenue growth 3Y92.26%
Revenue growth 5Y40.04%
Revenue growth Q2Q55.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

AUVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUVI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AUVI!.
Industry RankSector Rank
Dividend Yield N/A

APPLIED UV INC

NASDAQ:AUVI (5/1/2024, 7:00:01 PM)

After market: 0.585 +0.01 (+1.74%)

0.575

+0.01 (+1.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.08M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.38%
ROE -59.56%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.61
Quick Ratio 0.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-107.64%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y38.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)102.03%
Revenue growth 3Y92.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y